| Walid Khabbaz, MD | |
|
85 E Us Highway 6 Ste 310, Valparaiso, IN 46383 | |
| (219) 983-6380 | |
| (219) 983-6080 |
| Full Name | Walid Khabbaz |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 37 Years |
| Location | 85 E Us Highway 6 Ste 310, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669563342 | NPI | - | NPPES |
| 200262960 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 010-51874 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter Physician Services Llc | 1850482407 | 91 |
News Archive
Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas ("CPRIT").
Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR") has expired in connection with the previously announced cash tender offer made by Monarch Transaction Corp., a wholly owned subsidiary of Merck, to purchase all of the outstanding shares of common stock of Inspire.
The New York Times: "The weak economy is crippling the government program that provides life-sustaining antiretroviral drugs to people with H.I.V. or AIDS who cannot afford them. Nearly 1,800 have been relegated to rapidly expanding waiting lists that less than three years ago had dwindled to zero. ...
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
› Verified 5 days ago
| Entity Name | Porter Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508075680 PECOS PAC ID: 1850482407 Enrollment ID: O20070810000409 |
News Archive
Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas ("CPRIT").
Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR") has expired in connection with the previously announced cash tender offer made by Monarch Transaction Corp., a wholly owned subsidiary of Merck, to purchase all of the outstanding shares of common stock of Inspire.
The New York Times: "The weak economy is crippling the government program that provides life-sustaining antiretroviral drugs to people with H.I.V. or AIDS who cannot afford them. Nearly 1,800 have been relegated to rapidly expanding waiting lists that less than three years ago had dwindled to zero. ...
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Walid Khabbaz, MD 2022 Kelle Dr, Chesterton, IN 46304-8708 Ph: (219) 364-3616 | Walid Khabbaz, MD 85 E Us Highway 6 Ste 310, Valparaiso, IN 46383 Ph: (219) 983-6380 |
News Archive
Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas ("CPRIT").
Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR") has expired in connection with the previously announced cash tender offer made by Monarch Transaction Corp., a wholly owned subsidiary of Merck, to purchase all of the outstanding shares of common stock of Inspire.
The New York Times: "The weak economy is crippling the government program that provides life-sustaining antiretroviral drugs to people with H.I.V. or AIDS who cannot afford them. Nearly 1,800 have been relegated to rapidly expanding waiting lists that less than three years ago had dwindled to zero. ...
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
› Verified 5 days ago
Dr. Issa Rezek, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6 Ste 310, Valparaiso, IN 46383 Phone: 219-983-6380 Fax: 219-983-6080 | |
Peter I Rossi, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6 Ste 310, Valparaiso, IN 46383 Phone: 219-983-6380 Fax: 219-983-6080 |